ES2082626T3 - Dispositivo osmotico oral. - Google Patents

Dispositivo osmotico oral.

Info

Publication number
ES2082626T3
ES2082626T3 ES93901940T ES93901940T ES2082626T3 ES 2082626 T3 ES2082626 T3 ES 2082626T3 ES 93901940 T ES93901940 T ES 93901940T ES 93901940 T ES93901940 T ES 93901940T ES 2082626 T3 ES2082626 T3 ES 2082626T3
Authority
ES
Spain
Prior art keywords
wall
support material
fibrous support
mouth
passage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93901940T
Other languages
English (en)
Inventor
David Emil Edgren
Gurdish Kaur Bhatti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2082626T3 publication Critical patent/ES2082626T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Abstract

SE PRESENTA UN DISPOSITIVO OSMOTICO (10) PARA EL SUMINISTRO DE UN FARMACO BENEFICIOSO, TAL COMO UN FARMACO ANTIMICROBIANO, A LA BOCA DE UN PACIENTE HUMANO. EL DISPOSITIVO (10) TIENE UN TAMAÑO Y FORMA QUE SE PUEDEN ADAPTAR PARA QUE QUEDE RETENIDO DE FORMA COMODA EN LA BOCA DURANTE LARGOS PERIODOS DE TIEMPO. EL DISPOSITIVO CONSTA DE UNA PARED DE MEMBRANA SEMIPERMEABLE DELGADA (12) QUE RODEA A UN COMPARTIMIENTO (13) QUE ALOJA AL AGENTE BENEFICIOSO (14) QUE PRESENTA UN CIERTO GRADO DE SOLUBILIDAD EN FLUIDOS ACUOSOS BIOLOGICOS, EJ. LA SALIVA, Y UN MATERIAL DE SOPORTE FIBROSO (15) COMPUESTO DE FIBRAS HIDROFILICAS INSOLUBLES EN AGUA. UN ORIFICIO (17) FORMADO EN LA PARED (12) CONECTA EL AGENTE (14) CON EL EXTERIOR DEL DISPOSITIVO (10). LA PARED (12) ES PERMEABLE AL PASO DE FLUIDOS BIOLOGICOS ACUOSOS PERO SUSTANCIALMENTE IMPERMEABLE AL PASO DEL MATERIAL DE SOPORTE FIBROSO (15). EL MATERIAL DE SOPORTE FIBROSO (15), UNA VEZ HIDRATADO, PROPORCIONA UN SOPORTE RIGIDO A LA PARED SEMIPERMEABLE DELGADA (12)Y PREVIENE QUE EL AGENTE BENEFICIOSO (14) SALGA PREMATURAMENTE DEL DISPOSITIVO (10) INCLUSO CUANDO EL PACIENTE CHUPA EL DISPOSITIVO (10).
ES93901940T 1991-12-18 1992-12-18 Dispositivo osmotico oral. Expired - Lifetime ES2082626T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/809,741 US5200194A (en) 1991-12-18 1991-12-18 Oral osmotic device

Publications (1)

Publication Number Publication Date
ES2082626T3 true ES2082626T3 (es) 1996-03-16

Family

ID=25202119

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93901940T Expired - Lifetime ES2082626T3 (es) 1991-12-18 1992-12-18 Dispositivo osmotico oral.

Country Status (11)

Country Link
US (1) US5200194A (es)
EP (1) EP0617611B1 (es)
JP (1) JPH07506806A (es)
AT (1) ATE133561T1 (es)
AU (1) AU3333393A (es)
DE (1) DE69208104T2 (es)
DK (1) DK0617611T3 (es)
ES (1) ES2082626T3 (es)
MX (1) MX9207402A (es)
WO (1) WO1993011748A1 (es)
ZA (1) ZA929848B (es)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
AU691376B2 (en) * 1994-12-05 1998-05-14 Pauli, Gunter Method of drug delivery and coatings for use in the method
US5958450A (en) * 1994-12-05 1999-09-28 Phillip Peatey & Gunter Pauli Method of drug delivery and coated oral dosage forms for use in the method
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
US6074662A (en) * 1995-08-15 2000-06-13 Montgomery; Robert E. Proteinaceous animal chew with dentally therapeutic cation
FR2747570B1 (fr) * 1996-04-19 1998-07-24 Dogself Composition a effet antitartre et son utilisation dans des complements alimentaires pour animaux
US6030358A (en) * 1997-08-08 2000-02-29 Odland; Rick Matthew Microcatheter and method for site specific therapy
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
JP3718341B2 (ja) 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
CA2525555A1 (en) * 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
US6224579B1 (en) * 1999-03-31 2001-05-01 The Trustees Of Columbia University In The City Of New York Triclosan and silver compound containing medical devices
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
EP1054019A1 (en) * 1999-05-18 2000-11-22 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose
US20040215129A1 (en) * 1999-09-16 2004-10-28 Gambro Ab Method and cycler for the administration of a peritoneal dialysis fluid
US6680069B1 (en) 1999-11-09 2004-01-20 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose and process for manufacturing the same
JP3552160B2 (ja) 2000-01-14 2004-08-11 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース粒子の形成方法
US6770297B1 (en) * 2000-05-26 2004-08-03 Unitech Pharmaceuticals, Inc. Controlled release delivery system of solid dosage form
JP3595765B2 (ja) * 2000-09-27 2004-12-02 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
US7329412B2 (en) 2000-12-22 2008-02-12 The Trustees Of Columbia University In The City Of New York Antimicrobial medical devices containing chlorhexidine free base and salt
JP4675027B2 (ja) * 2001-04-20 2011-04-20 株式会社札幌イムノ・ダイアグノスティック・ラボラトリー 口腔内分泌液の採取兼回収器具
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
MXPA04002980A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosificacion que tienen un nucleo interior y coraza exterior con diferentes formas.
US7491407B2 (en) * 2001-10-31 2009-02-17 North Carolina State University Fiber-based nano drug delivery systems (NDDS)
US7328706B2 (en) * 2002-05-06 2008-02-12 Dynamic Mouth Devices Llc Therapeutic and protective dental device useful as an intra-oral delivery system
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040208908A1 (en) * 2003-04-16 2004-10-21 The Trustees Of Columbia University In The City Of New York Antimicrobial medical articles containing a synergistic combination of anti-infective compounds and octoxyglycerin
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
US20060095021A1 (en) * 2004-11-02 2006-05-04 Casas-Bejar Jesus W Introduction of agent with medical device
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2007016676A1 (en) * 2005-08-01 2007-02-08 Teva Pharmaceutical Industries Ltd. Tizanidine compositions and methods of treatment using the compositions
US20070048347A1 (en) 2005-08-26 2007-03-01 Laura Bardach Intra-oral device for treating obesity
EP1938842A4 (en) * 2005-09-01 2013-01-09 Eisai R&D Man Co Ltd METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION COMPRISING IMPROVED CRASHING CHARACTERISTICS
WO2007070795A2 (en) * 2005-12-12 2007-06-21 The Trustees Of Columbia University In The City Of New York Broad spectrum non-traditional preservative system
US20080044797A1 (en) * 2006-08-15 2008-02-21 Laura Bardach Inserts for use with oral appliances
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
CA2671092A1 (en) * 2006-11-30 2008-06-05 Accu-Break Technologies, Inc. Divisible osmotic dosage forms and methods of use
US20090035228A1 (en) * 2007-08-02 2009-02-05 Shanta Modak Skin and surface disinfectant compositions containing botanicals
US9687429B2 (en) * 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
WO2008157092A1 (en) * 2007-06-20 2008-12-24 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
US20100172848A1 (en) * 2008-08-01 2010-07-08 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
PT2456424E (pt) 2009-07-22 2013-09-30 Gruenenthal Gmbh Forma de dosagem resistente à adulteração e estabilizada contra a oxidação
MX2013002377A (es) 2010-09-02 2013-04-29 Gruenenthal Gmbh Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
CA2828946C (en) 2011-04-18 2016-06-21 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
ES2705950T3 (es) 2011-06-03 2019-03-27 Eisai R&D Man Co Ltd Biomarcadores para predecir y valorar la capacidad de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib
AR087360A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
MX348054B (es) 2011-07-29 2017-05-25 Gruenenthal Gmbh Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco.
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
WO2013067150A2 (en) 2011-11-03 2013-05-10 The Trustees Of Columbia University In The City Of New York Composition with sustained antimicrobial activity
TW201330856A (zh) 2011-12-06 2013-08-01 Univ Columbia 廣效性的天然防腐組成物
RS57913B1 (sr) 2012-04-18 2019-01-31 Gruenenthal Gmbh Farmaceutske dozne forme otporne na neovlašćenu upotrebu i naglo oslobađanje celokupne doze
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9074972B2 (en) 2012-05-16 2015-07-07 Dionex Corporation Surrogate addition device and a method of analyte concentration
US8574400B1 (en) 2012-05-25 2013-11-05 Kimberly-Clark Worldwide, Inc. Tissue comprising macroalgae
US9499941B2 (en) 2012-05-25 2016-11-22 Kimberly-Clark Worldwide, Inc. High strength macroalgae pulps
CN104755463A (zh) 2012-12-21 2015-07-01 卫材R&D管理有限公司 非晶态形式的喹啉衍生物及其生产方法
MX368099B (es) 2013-05-14 2019-09-19 Eisai R&D Man Co Ltd Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib.
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
BR112015029015A2 (pt) 2013-06-10 2017-07-25 Kimberly Clark Co estruturas de papel tissue em camadas compreendendo macroalgas
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
BR112016010482B1 (pt) 2013-11-26 2022-11-16 Grünenthal GmbH Preparação de uma composição farmacêutica em pó por meio de criomoagem
JO3783B1 (ar) 2014-08-28 2021-01-31 Eisai R&D Man Co Ltd مشتق كوينولين عالي النقاء وطريقة لإنتاجه
DK3263106T3 (da) 2015-02-25 2024-01-08 Eisai R&D Man Co Ltd Fremgangsmåde til undertrykkelse af bitterhed af quinolinderivat
CA2978226A1 (en) 2015-03-04 2016-09-09 Merck Sharpe & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
US10575976B2 (en) 2015-04-30 2020-03-03 Dynamic Mouth Devices, L.L.C. Method and apparatus for weight management utilizing an intra-oral device
CN107801379B (zh) 2015-06-16 2021-05-25 卫材R&D管理有限公司 抗癌剂
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
CN110859997B (zh) * 2018-12-20 2020-06-23 四川大学 具有成骨-抗炎-血糖三维响应结构的牙种植体及其制备方法
US10758329B1 (en) 2019-08-20 2020-09-01 Raymond L. Wright, III Hydrating mouth guard

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3173876A (en) * 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (es) * 1960-11-29
US3276586A (en) * 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) * 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) * 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) * 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4568535A (en) * 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US5021053A (en) * 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
ES2064117T3 (es) * 1990-07-23 1995-01-16 Alza Corp Dispositivo osmotico oral para el suministro de nicotina.

Also Published As

Publication number Publication date
US5200194A (en) 1993-04-06
DK0617611T3 (da) 1996-05-20
JPH07506806A (ja) 1995-07-27
WO1993011748A1 (en) 1993-06-24
EP0617611A1 (en) 1994-10-05
EP0617611B1 (en) 1996-01-31
MX9207402A (es) 1993-07-01
DE69208104T2 (de) 1996-05-30
AU3333393A (en) 1993-07-19
ZA929848B (en) 1994-01-13
ATE133561T1 (de) 1996-02-15
DE69208104D1 (de) 1996-03-14

Similar Documents

Publication Publication Date Title
ES2082626T3 (es) Dispositivo osmotico oral.
FI920164A0 (fi) Oralt osmotiskt medel med en drivande hydrogeldel.
US3916880A (en) Device for holding open the mouth
ES2111743T3 (es) Cateter de balon para dispensar medicacion.
NO930134L (no) Oral osmoseanordning for avgivelse av nikotin
ES2020824A6 (es) Jeringa osmotica.
AR241676A1 (es) Suministrador de agente beneficioso a un ambiente de uso.
DE3688391D1 (de) Kuenstliche druese zur implantation in den menschlichen koerper.
ES2077757T5 (es) Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.
US6533579B2 (en) Intraoral diffusion type administration device incorporated in removable dental restoration
CN2737385Y (zh) 变径式阴道消毒器
CN210961897U (zh) 口腔检视装置
CN211156939U (zh) 一种口护包
CN2292570Y (zh) 心脏引流管
RU12346U1 (ru) Устройство для лечения заболеваний полости рта
FR2084148A5 (en) Sterile water prepn device - for medical uses
JP2520734Y2 (ja) 歯科治療におけるうがい水用コップ受け台
AR026805A1 (es) Solucion acuosa estable de deoxifructosazina y las composiciones farmaceuticas que la contienen
IT8844018A0 (it) Catetere non inquinante composto da un tubo semirigido nel cui interno e' inserita una membrana o pellicola in forma di tubo che trattenuta scorre sull'esterno del catetere mentre questi e' spinto negli organi interni. il trovato evita il trasporto di batteri o materiale patogeno dall'esterno all'interno di un organismo vivente
JPH0422951U (es)
ES1004539U (es) Dispositivo auxiliar de desinfeccion para la dialisis peritoneal.
CN1364647A (zh) 一次性排毒美容灌肠器
ES2046065A1 (es) Dispositivo intercambiador de calor y humedad para respiracion mecanica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 617611

Country of ref document: ES